Literature DB >> 17667614

Pediatric keratoplasty in India: indications and outcomes.

Namrata Sharma1, Gaurav Prakash, Jeewan S Titiyal, Radhika Tandon, Rasik B Vajpayee.   

Abstract

PURPOSE: To analyze the indications and outcomes of pediatric corneal transplantation surgery in a tertiary eye care center in the developing world.
METHODS: In this longitudinal, retrospective study involving continuous cases, the records of 168 eyes of 154 children undergoing keratoplasty at a tertiary care center's specialized keratoplasty clinic during a 7-year period (1998-2004) were reviewed. The demography, etiology of opacification, visual acuity, and other findings were recorded. Intraoperative and postoperative details were reviewed. Major postoperative outcomes analyzed were visual acuity, graft survival, causes of graft failure, and follow-up duration.
RESULTS: Infectious keratitis (43%) was the most common indication for keratoplasty, followed by congenital glaucoma (16.6%) and corneal trauma (11.2%). Overall 77% graft survival was seen at 36 months, and better graft outcome was associated with younger age and longer regular follow-up. Postoperatively, a best-corrected visual acuity (BCVA) > 20/200 could be achieved in only 30.1% of eyes at the last follow-up. Graft failure was seen in 18.4% of eyes, with graft infection being the most frequent cause (50%). Moreover, graft infection was the most common cause of graft failure in all age groups.
CONCLUSIONS: In the developing world, infectious keratitis is the most common indication for pediatric keratoplasty and the most frequent cause of its failure.

Entities:  

Mesh:

Year:  2007        PMID: 17667614     DOI: 10.1097/ICO.0b013e318074ce2e

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  9 in total

Review 1.  The challenging management of pediatric corneal transplantation: an overview of surgical and clinical experiences.

Authors:  Antonio Di Zazzo; Stefano Bonini; Salvatore Crugliano; Michele Fortunato
Journal:  Jpn J Ophthalmol       Date:  2017-04-03       Impact factor: 2.447

2.  Descemet stripping automated endothelial keratoplasty in pediatric age group.

Authors:  Silvana Madi; Paolo Santorum; Massimo Busin
Journal:  Saudi J Ophthalmol       Date:  2012-05-12

Review 3.  Post-keratoplasty Infectious Keratitis: Epidemiology, Risk Factors, Management, and Outcomes.

Authors:  Anna Song; Rashmi Deshmukh; Haotian Lin; Marcus Ang; Jodhbir S Mehta; James Chodosh; Dalia G Said; Harminder S Dua; Darren S J Ting
Journal:  Front Med (Lausanne)       Date:  2021-07-07

4.  A baby with primary congenital glaucoma not responding to trabeculotomy.

Authors:  Mohammad-Reza Razeghinejad
Journal:  J Ophthalmic Vis Res       Date:  2014-04

5.  Graft rejection in pediatric penetrating keratoplasty: Clinical features and outcomes.

Authors:  Rakhi Kusumesh; Murugesan Vanathi
Journal:  Oman J Ophthalmol       Date:  2015 Jan-Apr

Review 6.  Upgradation and modernization of eye banking services: Integrating tradition with innovative policies and current best practices.

Authors:  Radhika Tandon; Archita Singh; Noopur Gupta; M Vanathi; Vivek Gupta
Journal:  Indian J Ophthalmol       Date:  2017-02       Impact factor: 1.848

7.  Indications and outcomes of pediatric keratoplasty in a tertiary eye care center: A retrospective review.

Authors:  Rosario Gulias-Cañizo; Roberto Gonzalez-Salinas; Luis Fernando Hernandez-Zimbron; Everardo Hernandez-Quintela; Valeria Sanchez-Huerta
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

8.  Eye Bank Records on Pediatric Keratoplasty.

Authors:  Seyed Mohamadmehdi Moshtaghion; Mohammad Abolhosseini; Bahareh Kheiri; Mohammad Ali Javadi; Leila Ziaee Ardakani; Mozhgan Rezaei Kanavi
Journal:  J Ophthalmic Vis Res       Date:  2022-08-15

9.  Comparison of ocular axis and corneal diameter between entropion and non-entropion eyes in children with congenital glaucoma.

Authors:  Yue Wang; Zhi-Jia Hou; Huai-Zhou Wang; Man Hu; Yu-Xin Li; Zheng Zhang
Journal:  World J Clin Cases       Date:  2021-06-26       Impact factor: 1.337

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.